Besides, subsequent exploration suggested that TRIM9 shRNA treatment resulted in increased mRNA and protein expression of stem-like phenotypic biomarkers on tumor cells, including CD133 and CD44, whereas TRIM9 overexpression demonstrated completely opposite effects (Figures 3(e) and 3(f)). The gene discussed is TRIM9; the disease is neoplasm.